selenOmed GmbH
selenOmed GmbH develops and provides diagnostic tools and services for the analysis of selenium status in humans.
About
selenOmed GmbH, founded in 2017 by Prof. Lutz Schomburg, is a German biotechnology company based in Berlin that specializes in developing and offering diagnostic tools and laboratory services to analyze selenium status in humans. The company provides quantitative analysis of various serum parameters related to selenium, including selenoprotein P, selenium concentration, selenoprotein P autoantibodies, and extracellular glutathione peroxidase. selenOmed's products are primarily intended for research use and enable monitoring of selenium supplementation and deficiency, which are important for diverse health aspects, including autoimmune, metabolic, and cancer-related conditions.
Products & Services
- selenOtest ELISA (enzyme-linked immunoassay for human selenoprotein P)
- Anti-SELENOP monoclonal antibody (for detection of human selenoprotein P)
- Anti-IR monoclonal antibody (for detection of human insulin receptor)
- Teprotest (IGF1R autoantibody detection kit)
- IRaBtest (Insulin receptor autoantibody detection kit)
- Comprehensive quantitative serum analysis of selenium status (selenium, SELENOP, SELENOP autoantibodies, GPX3)
Use Cases & Case Studies
- SELENOP ELISA and other kits used in a broad range of peer-reviewed clinical and research studies on selenium status, various diseases such as cancer, cardiovascular disease, autoimmune disorders, metabolic diseases, pregnancy, and COVID-19 (extensive reference list provided on site)
Partnerships & Collaborations
-
Awards & Recognition
-
Contact Information
Certifications & Compliance
- CE marking documentation available for selenOtest ELISA (see website PDF link)